Previous close | 112.04 |
Open | 112.26 |
Bid | 111.00 x 800 |
Ask | 113.43 x 800 |
Day's range | 111.23 - 112.53 |
52-week range | 74.88 - 116.04 |
Volume | |
Avg. volume | 2,412,865 |
Market cap | 27.218B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 44.40 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.00 (1.79%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Walgreens Boots' (WBA) comparable pharmacy sales in the fiscal second quarter benefited from higher branded drug inflation and strong execution in pharmacy services.
GE HealthCare (GEHC) announces the launch of Prostate Volume Assist AI-enabled urology software feature, which is likely to boost prostate imaging, capture prostate volume and increase workflow.